Сonfirmatory study of the efficacy and tolerability of trifluridine/tipiracil (TAS-102) therapy in the Russian population with chemorefractory metastatic colorectal cancer

Introduction. Trifluridine/Tipiracil (FTD/TPI) is a new chemotherapeutic drug approved in more than 60 countries for use in patients with metastatic colorectal cancer who have registered progression or intolerance to treatment with fluoropyrimidines, oxaliplatin and irinotecan, anti-VEGRand anti-EGF...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: M. Yu. Fedyanin, F. V. Moiseenko, D. A. Chekini, V. A. Chubenko, A. S. Zhabina, L. A. Zagorskaya, M. M. Kramchaninov, S. A. Tjulandin, V. M. Moiseyenko
Formato: Artigo
Idioma:Russo
Publicado: Remedium Group LLC 2020-12-01
Series:Медицинский совет
Assuntos:
trifluridine/tipiracil
tas-102
metastatic cancer
colorectal
chemotherapy
targeted therapy
Acceso en liña:https://www.med-sovet.pro/jour/article/view/5934
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares